載入中
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
前收盤價
US$0.689
+US$0.0139 · +2.06%
盤中時間採用ET。市場資料可能有所延遲。
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
日內區間
目前US$0.689
52週區間
目前US$0.689
盤中時間採用ET。市場資料可能有所延遲。
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
日內區間
目前US$0.689
52週區間
目前US$0.689
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 827萬 USD | 874萬 USD | 886.4萬 USD | 854.3萬 USD | 792.1萬 USD |
| 銷貨成本 | 314.6萬 USD | 291.4萬 USD | 388.1萬 USD | 378.8萬 USD | 343萬 USD |
| 毛利 | 512.4萬 USD | 582.6萬 USD | 498.3萬 USD | 475.5萬 USD | 449.1萬 USD |
| 研究與開發 | 271.2萬 USD | 320.9萬 USD | 542.2萬 USD | 434.2萬 USD | 497.8萬 USD |
| 銷售、一般及管理費用 | 1351.8萬 USD | — | 1719.1萬 USD | 1758.4萬 USD | 1903.9萬 USD |
| 營業費用 | 1623萬 USD | 1681.4萬 USD | 2261.3萬 USD | 2192.6萬 USD | 2401.7萬 USD |
| 利息支出 | 1055.3萬 USD | 560.7萬 USD | 348.3萬 USD | 924.7萬 USD | — |
| 折舊和攤銷 | 41.7萬 USD | 31萬 USD | 36.2萬 USD | 37.2萬 USD | 48.8萬 USD |
| 營業利益 | −1110.6萬 USD | −1098.8萬 USD | −1763萬 USD | −1717.1萬 USD | −1952.6萬 USD |
| 淨利 | −1752.1萬 USD | −1116.5萬 USD | −2020.9萬 USD | −1452.5萬 USD | −1955.4萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
